FDG Whole-Body PET/MRI in Oncology: a Systematic Review

[1]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[2]  S. Baba,et al.  Comparison of positron emission tomography diffusion‐weighted imaging (PET/DWI) registration quality in a PET/MR scanner: Zoomed DWI vs. Conventional DWI , 2016, Journal of magnetic resonance imaging : JMRI.

[3]  H. Chandarana,et al.  Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy , 2016, Journal of magnetic resonance imaging : JMRI.

[4]  N. Schwenzer,et al.  Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to 18F-Fluorodeoxyglucose Positron Emission Tomography/Compu , 2016, Investigative radiology.

[5]  Kyoungjune Pak,et al.  Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers , 2016, Clinical nuclear medicine.

[6]  G. V. von Schulthess,et al.  TNM Staging of Non–Small Cell Lung Cancer: Comparison of PET/MR and PET/CT , 2016, The Journal of Nuclear Medicine.

[7]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[8]  Kevin M. Johnson,et al.  Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. , 2016, Radiology.

[9]  Osman Ratib,et al.  Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging , 2016, European Radiology.

[10]  T. Allkemper,et al.  [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  B. Sheu,et al.  Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole‐body PET/MR: Correlation with pathological prognostic factors , 2015, Journal of magnetic resonance imaging : JMRI.

[12]  Patrick Veit-Haibach,et al.  18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT , 2015, Nuclear medicine communications.

[13]  Michael Forsting,et al.  Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT. , 2015, European journal of radiology.

[14]  N. Schwenzer,et al.  Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data , 2015, Journal of magnetic resonance imaging : JMRI.

[15]  G. Cheon,et al.  Presurgical Mapping of Brain Tumors Using Statistical Probabilistic Anatomical Maps , 2015 .

[16]  P. Heusch,et al.  Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases , 2015, PloS one.

[17]  M. Fenchel,et al.  (18)F-FDG PET/MRI for therapy response assessment in sarcoma: comparison of PET and MR imaging results. , 2015, Clinical imaging.

[18]  A. Rosenkrantz,et al.  Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer , 2015, Clinical nuclear medicine.

[19]  Harald H Quick,et al.  Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging , 2015, Investigative radiology.

[20]  M. Aiello,et al.  Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation. , 2015, European journal of radiology.

[21]  H. Quick,et al.  Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading. , 2015, European journal of radiology.

[22]  K. Herrmann,et al.  Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study , 2015, Abdominal Imaging.

[23]  Sang Min Lee,et al.  Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging? , 2015, PloS one.

[24]  G. Antoch,et al.  Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT? , 2015, Nuclear medicine communications.

[25]  P. Veit-Haibach,et al.  PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison , 2015, European Radiology.

[26]  Sang Min Lee,et al.  PET/MR Imaging for Chest Diseases: Review of Initial Studies on Pulmonary Nodules and Lung Cancers. , 2015, Magnetic resonance imaging clinics of North America.

[27]  B R Rosen,et al.  Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients , 2015, British Journal of Cancer.

[28]  A. Wetter,et al.  Thoracic staging of non-small-cell lung cancer using integrated 18F-FDG PET/MR imaging: diagnostic value of different MR sequences , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  H. Chandarana,et al.  PET/MRI for the evaluation of patients with lymphoma: initial observations. , 2015, AJR. American journal of roentgenology.

[30]  K. Ates,et al.  Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT , 2015 .

[31]  M. Aznar,et al.  Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR. , 2015, The British journal of radiology.

[32]  P. Heusch,et al.  Integrated 18F-FDG PET/MR Imaging in the Assessment of Cardiac Masses: A Pilot Study , 2015, The Journal of Nuclear Medicine.

[33]  S. Matsumoto,et al.  Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. , 2015, Radiology.

[34]  P. Heusch,et al.  Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Lymph Node Metastases of Non-Small Cell Lung Cancer (NSCLC) Patients Using Hybrid 18F-FDG PET/MRI , 2015, PloS one.

[35]  N. Schwenzer,et al.  Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  G. Delso,et al.  TNM staging of NSCLC: Comparison of PET/MR and PET/CT , 2015 .

[37]  Gerald Antoch,et al.  Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  Michael Forsting,et al.  Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging for Whole-Body Staging in Patients With Recurrent Gynecological Malignancies of the Pelvis: A Comparison to Whole-Body Magnetic Resonance Imaging Alone , 2014, Investigative radiology.

[39]  M. Forsting,et al.  Diagnostic Value of Diffusion-Weighted Imaging in Simultaneous 18F-FDG PET/MR Imaging for Whole-Body Staging of Women with Pelvic Malignancies , 2014, The Journal of Nuclear Medicine.

[40]  C. Claussen,et al.  Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: Comparison with 18F‐FDG‐PET , 2014, Journal of magnetic resonance imaging : JMRI.

[41]  J. van den Hoff,et al.  FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR. , 2014, Academic radiology.

[42]  M. Schluchter,et al.  Qualitative and Quantitative Performance of 18F-FDG-PET/MRI versus 18F-FDG-PET/CT in Patients with Head and Neck Cancer , 2014, American Journal of Neuroradiology.

[43]  Jaetae Lee,et al.  Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma. , 2014, Hellenic journal of nuclear medicine.

[44]  F. Zaccagna,et al.  Non-small-cell lung cancer resectability: diagnostic value of PET/MR , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[45]  G. V. von Schulthess,et al.  Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations. , 2014, Radiology.

[46]  Patrick Veit-Haibach,et al.  Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  Kyoungjune Pak,et al.  Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.

[48]  Michael Laniado,et al.  FDG PET/MR for lymph node staging in head and neck cancer. , 2014, European journal of radiology.

[49]  K. Sugimura,et al.  Fusion of PET and MRI for staging of uterine cervical cancer: comparison with contrast-enhanced (18)F-FDG PET/CT and pelvic MRI. , 2014, Clinical imaging.

[50]  Wolfgang Bogner,et al.  Improved Differentiation of Benign and Malignant Breast Tumors with Multiparametric 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging: A Feasibility Study , 2014, Clinical Cancer Research.

[51]  Felix Nensa,et al.  Whole-body [18F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results , 2014, European Radiology.

[52]  Sergios Gatidis,et al.  Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. , 2014, Radiology.

[53]  Sebastian Fürst,et al.  PET/MR Imaging in the Detection and Characterization of Pulmonary Lesions: Technical and Diagnostic Evaluation in Comparison to PET/CT , 2014, The Journal of Nuclear Medicine.

[54]  Abhishek Jha,et al.  Simultaneous PET/MRI: Impact on cancer management-A comprehensive review of cases , 2014, Indian Journal of Radiology and Imaging.

[55]  Patrick Veit-Haibach,et al.  Contrast-Enhanced PET/MR Imaging Versus Contrast-Enhanced PET/CT in Head and Neck Cancer: How Much MR Information Is Needed? , 2014, The Journal of Nuclear Medicine.

[56]  Byung Il Kim,et al.  Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18 F-FDG PET/CT and MRI , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  L. Fu,et al.  Does the Novel Integrated PET/MRI Offer the Same Diagnostic Performance as PET/CT for Oncological Indications? , 2014, PloS one.

[58]  Andrea Soricelli,et al.  Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. , 2014, European journal of radiology.

[59]  D. Loeffelbein,et al.  Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions , 2014, The Journal of Nuclear Medicine.

[60]  Dong Soo Lee,et al.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology , 2014, Nuclear Medicine and Molecular Imaging.

[61]  A. Afaq,et al.  Qualitative and Quantitative Comparison of PET/CT and PET/MR Imaging in Clinical Practice , 2014, The Journal of Nuclear Medicine.

[62]  Giuseppe Rubini,et al.  Useful diagnostic biometabolic data obtained by PET/CT and MR fusion imaging using open source software. , 2014, Hellenic journal of nuclear medicine.

[63]  M. Forsting,et al.  [18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[64]  Patrick Veit-Haibach,et al.  Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  O. Sabri,et al.  Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[66]  Hongzan Sun,et al.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  G. Cheon,et al.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.

[68]  Andrea Soricelli,et al.  Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. , 2013, Radiology.

[69]  Felix Nensa,et al.  Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI. , 2013, European journal of radiology.

[70]  K. Sugimura,et al.  Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. , 2013, European journal of radiology.

[71]  David Faul,et al.  Comparison of the accuracy of PET/CT and PET/MRI spatial registration of multiple metastatic lesions. , 2013, AJR. American journal of roentgenology.

[72]  Habib Zaidi,et al.  Detection and quantification of focal uptake in head and neck tumours: 18F-FDG PET/MR versus PET/CT , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[73]  K. Sugimura,et al.  Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. , 2013, European journal of radiology.

[74]  J. L. Vercher-Conejero,et al.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: Initial experience , 2013, European Radiology.

[75]  G. V. von Schulthess,et al.  PET/CT versus body coil PET/MRI: how low can you go? , 2013, Insights into Imaging.

[76]  H. Alkadhi,et al.  Detection Rate, Location, and Size of Pulmonary Nodules in Trimodality PET/CT-MR: Comparison of Low-Dose CT and Dixon-Based MR Imaging , 2013, Investigative radiology.

[77]  W. Kalender,et al.  Integrated Whole-Body PET/MR Hybrid Imaging: Clinical Experience , 2013, Investigative radiology.

[78]  M. Forsting,et al.  Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection? , 2013, European journal of radiology.

[79]  Hideyuki Wakamatsu,et al.  The usefulness of 18F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with 18F-FDG PET/CT , 2013, Annals of Nuclear Medicine.

[80]  D. Jeon,et al.  18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Y. Huan,et al.  The value of apparent diffusion coefficient in the assessment of cervical cancer , 2013, European Radiology.

[82]  T. Jochimsen,et al.  PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner , 2013, Pediatric Radiology.

[83]  A. Drzezga,et al.  First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.

[84]  M. Uder,et al.  Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[85]  Zhang Lin,et al.  Sensitivity of PET/MR images in liver metastases from colorectal carcinoma. , 2011, Hellenic journal of nuclear medicine.

[86]  Wei-Che Lin,et al.  A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma , 2011, Clinical nuclear medicine.

[87]  Masatoshi Hori,et al.  18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT , 2011, International Journal of Clinical Oncology.

[88]  Bernd J. Pichler,et al.  Feasibility of simultaneous PET/MR imaging in the head and upper neck area , 2011, European Radiology.

[89]  G. V. von Schulthess,et al.  Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA–Enhanced MRI , 2010, Journal of Nuclear Medicine.

[90]  Hiroki Kato,et al.  Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography , 2010, Japanese Journal of Radiology.

[91]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[92]  Min Suk Kim,et al.  Prediction Model of Chemotherapy Response in Osteosarcoma by 18F-FDG PET and MRI , 2009, Journal of Nuclear Medicine.

[93]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[94]  T. Chen,et al.  The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma. , 2009, Academic radiology.

[95]  J. Lárraga-Gutiérrez,et al.  Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico. , 2008, Revista espanola de medicina nuclear.

[96]  Leonard Wartofsky,et al.  Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer. , 2008, Thyroid : official journal of the American Thyroid Association.

[97]  R. Felix,et al.  Impact of FDG-PET/MRI Image Fusion on the Detection of Pancreatic Cancer , 2007, Pancreatology.

[98]  K. Schmiegelow,et al.  Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[99]  Erik von Elm,et al.  Different patterns of duplicate publication: an analysis of articles used in systematic reviews. , 2004, JAMA.

[100]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.

[101]  D. Rennie,et al.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. , 2003, Annals of internal medicine.

[102]  U. Spetzger,et al.  Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation , 2001, European Journal of Nuclear Medicine.

[103]  J. Affeldt,et al.  The feasibility study , 2019, The Information System Consultant’s Handbook.